Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diethylamine | HCID 8021 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) | HCID 9886157 | — |
| Reactant | HCID 59809549 | HCID 59809549 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 11633937 | HCID 11633937 | 29% |
| Product | HCID 11641609 | HCID 11641609 | 28% |
Reaction Steps
To a solution of 10-(1-benzyl-piperidin-4-yl)-6-methoxy-10H-phenoxazine-3-carboxylic acid, 3d (240 mg, 0.56 mmol) in DMF was added HATU (424 mg, 1.11 mmol), N,N-diisopropyl-N-ethylamine (115 mg, 1.12 mmol), and N,N-diethylamine (82 mg, 1.12 mmol). The mixture was allowed to stir overnight at rt. Water (5 mL) was added, and the solution was extracted with EtOAc. The organic layer was separated, dried, and evaporated. The residue was purified via reverse phase HPLC (eluent: CH3CN in water containing 0.1% TFA) to yield 93.3 mg (28%) of 10-(1-benzyl-piperidin-4-yl)-6-methoxy-10H-phenoxazine-3-carboxylic acid diethylamide, 4d and 91.4 mg (29%) of 10-(1-benzyl-piperidin-4-yl)-6-methoxy-10H-phenoxazine-3-carboxylic acid dimethylamide, 5d, both as TFA salts (presence of 5d is presumably due to N,N-dimethylamine present in DMF). 4d: MS m/z (MH+) 486.0; 5d: MS m/z (MH+) 458.8.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07432257B2 |
|---|
| Source dataset | uspto-grants-2008_10 |
|---|
| ORD ID | ord-eb21d20be7d3439e8b16a294dccbf1c0 |
|---|
| Source note | uspto-grants-2008_10 |
|---|
